Skip to content
DataLookout
Menu

NCT07904234

Impact of Closed PBSC Collection With Reduced Gas-Phase Oxygen Exposure on Graft Quality and Early Engraftment in Allo-HSCT

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Start date pushed from Oct 1, 2026 to Nov 1, 2026
    • Primary and study completion pushed from Sep 30, 2029 to Oct 30, 2029
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Time to Neutrophil Engraftment
Timeframe: Up to Day 30 post-transplant

Secondary (11)

pO₂ of PBSC Collection Product
ROS Levels in CD34⁺ Cells
CD34⁺ HSPC Viability
CFU Formation Capacity of CD34⁺ HSPCs
Correlation Between Collection Product pO₂ and Time to ANC Engraftment
Show 6 moreShow less
Correlation Between Collection Product pO₂ and Time to PLT Engraftment
Time to Platelet Engraftment
Incidence of Poor Engraftment
Early Donor Chimerism
Incidence of Donor Adverse Events During and After PBSC Collection
Incidence of Recipient Adverse Events After Transplant

Arms and interventions

Low-Oxygen Closed PBSC CollectionExperimental
Standard PBSC CollectionNo intervention

Procedures: Closed PBSC collection with reduced gas-phase oxygen exposure

Sites

1 site in 1 country

  • National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College HospitalTianjin, Tianjin Municipality, China